Skip to content

Clinical trials

Observational Hepatitis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis Phase: Observational Clear all

83 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20013
20021
20032
20041
20062
20072
20095
20102
20113
20122
20135
20146
20152
20162
20172
20183
20194
20203
20217
20222
20236
20246
20256
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41
Unknown status17
Recruiting11
Terminated4
Not yet recruiting3
Withdrawn2
Enrolling by invitation2
Active, not recruiting2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline4
National Heart, Lung, and Blood Institute (NHLBI)3
AbbVie2
All India Institute of Medical Sciences2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2
National Institutes of Health Clinical Center (CC)2
The First Hospital of Jilin University2
University Hospital, Montpellier2
University of Aarhus2
University of North Carolina, Chapel Hill2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis83
Hepatitis C17
Liver Cirrhosis11
Liver Diseases11
Hepatitis B10
Fibrosis7
Fatty Liver6
HIV Infections6
Non-alcoholic Fatty Liver Disease6
Carcinoma, Hepatocellular5

Trials

Showing 51 to 75 of 83. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.